Acceptance of an Mpox Vaccine in the Democratic Republic of the Congo: Results from a Nationwide Phone Survey

Skylar Petrichko,Jason Kindrachuk,Dalau Nkamba,Megan Halbrook,Sydney Merritt,Handdy Kalengi,Leonard Kamba,Michael Beya,Nicole A. Hoff,Christophe Luhata,Didine K. Kaba,Anne W. Rimoin
DOI: https://doi.org/10.1101/2024.08.15.24311971
2024-09-04
Abstract:We report general acceptance of an mpox vaccine (61.0%) in the Democratic Republic of the Congo (n=5226) with higher acceptance among healthcare workers and respondents in historic mpox-endemic regions. These data highlight the need for increased community engagement and sensitization before widespread deployment of the mpox vaccine.
Public and Global Health
What problem does this paper attempt to address?